Even within breast tumors, the accepted combination of surface markers CD44/CD24 shows differences among different subtypes, being the CD44+/CD24− phenotype common in the basal subtype, specially in BRCA1 hereditary tumors, but surprisingly scarce in HER2-positive tumors (36). Here, CD24 is linked to breast neoplasm.